Hematology
Eltrombopag
$10.00
Universal Activity Number: 407-000-10-019-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
Article title:
view more on 407-000-10-019-H01-P
Eltrombopag: A Novel Oral Thrombopoietin Receptor Agonist
Plerixafor for Stem Cell Mobilization
$8.00
Universal Activity Number: 407-000-10-054-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 03/01/2010
Expiration date: 03/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 03/01/2010
Expiration date: 03/01/2013
Article title:
view more on 407-000-10-054-H01-P
Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplant in Non- Hodgkin’s Lymphoma and Multiple Myeloma
Plerixafor
$10.00
Universal Activity Number: 407-000-10-005-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 01/01/2010
Expiration date: 01/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 01/01/2010
Expiration date: 01/01/2013
Article title:
view more on 407-000-10-005-H01-P
Plerixafor for Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma and Multiple Myeloma
Sapropterin
$10.00
Universal Activity Number: 407-000-09-015-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 09/01/2009
Expiration date: 09/01/2012
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 09/01/2009
Expiration date: 09/01/2012
Article title:
view more on 407-000-09-015-H01-P
Sapropterin: A New Therapeutic Agent for Phenylketonuria
Denosumab
$10.00
Universal Activity Number: 407-000-09-016-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 09/01/2009
Expiration date: 09/01/2012
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 09/01/2009
Expiration date: 09/01/2012
Article title:
view more on 407-000-09-016-H01-P
Denosumab in Osteoporosis and Oncology